R

Rocket Pharmaceuticals
D

RCKT

11.270
USD
-0.30
(-2.59%)
Market Open
Volume
14,042
EPS
-2
Div Yield
-
P/E
-4
Market Cap
1,195,228,835
OverviewSignalsIdeasNews
Related Instruments
    A
    ASTC
    -0.02500
    (-0.35%)
    7.16000 USD
    BA
    BA
    -1.560
    (-0.88%)
    175.770 USD
    GD
    GD
    0.50
    (0.19%)
    264.16 USD
    K
    KTOS
    0.150
    (0.58%)
    26.030 USD
    LMT
    LMT
    -4.07
    (-0.83%)
    484.34 USD
    M
    MAXR
    0
    (0%)
    0.000000 USD
    NOC
    NOC
    -2.95
    (-0.63%)
    466.55 USD
    RTX
    RTX
    -0.180
    (-0.15%)
    116.220 USD
    S
    SPCE
    0.08000
    (1.31%)
    6.18000 USD
    U
    U
    -0.070
    (-0.31%)
    22.390 USD
    More
News

Title: Rocket Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.